The promise of retinoids to fight against cancer
The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
Retinoids have a reputation for being both detrimental and beneficial: they are teratogens, but they also have tumour-suppressive capacity. Cell biology and genetics have significantly improved our understanding of the mechanisms that underlie the anti-proliferative action of retinoids. Recent elucidation of the pathways that are activated by retinoids will help us to exploit the beneficial aspects of this powerful class of compounds for cancer therapy and prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Apart from the well-known indications in hypovitaminosis and skin diseases, retinoids have been successfully used in treating cancer”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
In the citing paper
“The FDA has approved ATRA to treat cystic acne and several cancers, such as some lymphoma and leukemia”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
Citations
Cites
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233 · cited 8×
“a | The t(15;17) chromosomal translocation generates the PML–RARα fusion protein that, in contrast to RARα, can efficiently dimerize or oligomerize, thereby recruiting multiple HDAC complexes and leading to ‘super-repression’ of target genes.”
BackgroundInfluentialKamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411601 · Cited by 1,898
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics
McPherson, K. (2000) · BMJ · doi:10.1136/bmj.321.7261.624 · Cited by 1,570
Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231205 · Cited by 1,365
The retinoids—Biology, chemistry and medicine
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80793-5 · Cited by 1,178
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Embryonic retinoic acid synthesis is essential for early mouse post-implantation development
Niederreither, K., Subbarayan, V., Dollé, P., & Chambon, P. (1999) · Nature Genetics · doi:10.1038/7788 · Cited by 1,077
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
BackgroundGrignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
Background
Research works printed but not linked: 1
- Moon, R. C., Mehta, R. G. & Rao, K. J. V. N. in The Retinoids (eds Sporn, M. B., Roberts, A. B. & Goodman, D. S.) 573–595 (Raven, New York, 1994).
Cited by
Items 401–500 of 784
Maltman, D. J., Christie, V. B., Collings, J. C., Barnard, J. H., Fenyk, S., Marder, T. B., Whiting, A., & Przyborski, S. A. (2009) · Molecular BioSystems · doi:10.1039/b817912c · Cited by 22
Guruvayoorappan, C., & Kuttan, G. (2007) · Nutrition Research · doi:10.1016/j.nutres.2007.04.009 · Cited by 24
Leukemia: beneficial actions of retinoids and rexinoids
Altucci, L., Wilhelm, E., & Gronemeyer, H. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00247-4 · Cited by 26
Self-citationLerche, C. M., Philipsen, P. A., Sehested, M., & Wulf, H. C. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00733.x · Cited by 22
Zyxin cooperates with PTOV1 to confer retinoic acid resistance by repressing RAR activity
Youn, H., Kim, E., & Um, S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.12.019 · Cited by 21
Hyter, S. D., & Indra, A. K. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.041 · Cited by 22
“Unfortunately, the use of pan-retinoids is limited due to unwanted side effects such as skin irritation, hypertriglyceridemia, bone toxicity and teratogenicity [49,50].”
BackgroundZhu, Y., Liu, Y., Yang, F., Chen, W., Jiang, J., He, P., Jiang, S., Li, M., & Xu, R. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01973-8 · Cited by 22
Um, S., Han, H., Kwon, Y., Park, S., Rho, Y., Sin, H., & Park, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11489 · Cited by 21
Cianférani, S., Bourguet, W., Germain, P., Chavant, V., Moras, D., Gronemeyer, H., Potier, N., & DORSSELAER, A. V. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04466.x · Cited by 23
Self-citationRetinoids and skin: Microarrays shed new light on chemopreventive action of all‐trans retinoic acid
Cheepala, S., Syed, Z., Trutschl, M., Cvek, U., & Clifford, J. L. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20346 · Cited by 21
“Retinoid treatment has been postulated to restore the normal epithelial differentiation state of the tumor cells in these cases, possibly by overriding the effect of retinoid receptor loss [27].”
BackgroundVegetarian diet and reduced uterine fibroids risk: A case–control study in Nanjing, China
Shen, Y., Wu, Y., Lu, Q. R., & Ren, M. (2015) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12834 · Cited by 20
“idants and phytochemicals that may decrease uterine fibroids risk via apoptosis or hormone-dependent pathways.(7,28,29) For example, phytoestrogens can com-”
BackgroundKumaresan, N., Sanjay, K. R., Venkatesh, K. S., Kadeppagari, R., Govindaswamy, V., & Umesh-Kumar, S. (2008) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1538-7 · Cited by 20
“Retinoids, a group of natural and synthetic derivatives of vitamin A (Niles 2004), mediate cell signaling through retinoic acid and retinoid X nuclear receptors to restore normalcy in abnormal animal cells (de Luca 1991; Li et al. 1998; Altucci and Gronemeyer 2001 ).”
BackgroundInfluentialRetinoic Acid Receptor Alpha Amplifications and Retinoic Acid Sensitivity in Breast Cancers
Alsafadi, S., Even, C., Falet, C., Goubar, A., Commo, F., Scott, V., Quidville, V., Albiges, L. K., Dieci, M. V., Guégan, J., et al. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.02.001 · Cited by 21
Dominant-negative Retinoic Acid Receptors Elicit Epidermal Defects through a Non-canonical Pathway
Chen, C. F., & Lohnes, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411522200 · Cited by 20
Pharmacotherapy of neuroblastoma
George, R. E., Diller, L., & Bernstein, M. L. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.482100 · Cited by 26
“It is hypothesized that HDAC inhibitors potentiate the de-repression of retinoid-responsive genes in the presence of ligand [100].”
BackgroundNon-classical Transcriptional Activity of Retinoic Acid
Noy, N. (2016) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-024-0945-1_7 · Cited by 23
PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer
Baba, H., Kanda, M., Sawaki, K., Umeda, S., Miwa, T., Shimizu, D., Tanaka, C., Kobayashi, D., Fujiwara, M., Kodera, Y., et al. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07985-6 · Cited by 20
Endogenous and combination retinoids are active in myelomonocytic leukemias
di Martino, O., Niu, H., Hadwiger, G., Kuusanmäki, H. A., Ferris, M. A., Vu, A., Beales, J. T., Wagner, C. E., Menéndez-Gutierrez, M. P., Ricote, M., et al. (2020) · Haematologica · doi:10.3324/haematol.2020.264432 · Cited by 22
An EGF receptor inhibitor induces RAR-β expression in breast and ovarian cancer cells
Grunt, T. W., Puckmair, K., Tomek, K., Kainz, B., & Gaiger, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.104 · Cited by 20
Luo, P., Lin, M., Li, L., Yang, B., & He, Q. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027298 · Cited by 20
Xu, F., Li, K., Tian, M., Hu, P., Song, W., Chen, J., Gao, X., & Zhao, Q. (2009) · Mechanisms of Development · doi:10.1016/j.mod.2009.09.001 · Cited by 20
“Inappropriate gain of N-CoR function, mostly due to lack of proper dissociation of N-CoR from nuclear receptors, leads to repression of transcription despite the presence of ligand and causes a variety of diseases, including the human acute promyelocytic leukemia (APL) (Altucci and Gronemeyer, 2001; Jepsen and Rosenfe…”
Influentialvan Eijl, S., Mortaz, E., Versluis, C., Nijkamp, F. P., Folkerts, G., & Bloksma, N. (2011) · PubMed · Cited by 20
Klopper, J. P., Sharma, V., Berenz, A., Hays, W. R., Loi, M. M., Pugazhenthi, U., Said, S., & Haugen, B. R. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-16 · Cited by 20
“Retinoid receptors can be divided into two broad categories of retinoic acid receptors (RAR) and retinoid × receptors (RXR), each with three separate isotypes encoded by 6 different genes (RAR α, β, γ and RXR α, β, γ)[4,5].”
BackgroundYin, W., Raffelsberger, W., & Gronemeyer, H. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.03.003 · Cited by 20
Self-citationOvercoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids
Hernandez, D., Palau, L., Norsworthy, K. J., Anders, N. M., Alonso, S., Su, M., Petkovich, M. P., Chandraratna, R., Rudek, M. A., Smith, B. D., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0790-4 · Cited by 19
Ando, N., Shimizu, M., Okuno, M., Matsushima‐Nishiwaki, R., Tsurumi, H., Tanaka, T., & Moriwaki, H. (2007) · Oncology Reports · doi:10.3892/or.18.4.879 · Cited by 19
Khandelwal, A., Gediya, L. K., & Njar, V. C. O. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604295 · Cited by 21
“Retinoids, rexinoids, retinoid-related molecules (RRMs) and histone deacetylase inhibitors (HDACIs) have shown promising biological activities as single agents in several preclinical studies of both haematological and solid malignancies (Altucci and Gronemeyer, 2001; Lindemann et al, 2004; Bolden et al, 2006; Njar et…”
BackgroundVerheul, H. M. W., Qian, D. Z., Carducci, M. A., & Пили, Р. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0379-2 · Cited by 19
“The use of diVerentiation inducing compounds is gaining an increased interest as a therapeutic strategy in cancer treatment [1].”
BackgroundEngedal, N., Auberger, P., & Blomhoff, H. K. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107790 · Cited by 20
“RA and retinoids are promising anticancer agents, as monotherapy or in combination with other therapeutic drugs [78].”
BackgroundRetinoid receptor cross-talk in respiratory epithelium cancer chemoprevention
Karamouzis, M. V., & Papavassiliou, A. G. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.11.006 · Cited by 22
Local Skin Pharmacokinetics of Talarozole, a New Retinoic Acid Metabolism-Blocking Agent
Baert, B., & Spiegeleer, B. M. J. D. (2011) · Skin Pharmacology and Physiology · doi:10.1159/000323012 · Cited by 21
Soria, J., Xu, X., Liu, D. D., Lee, J. J., Kurie, J. M., Morice, R. C., Khuri, F. R., Li, M., Hong, W. K., & Lotan, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.165 · Cited by 19
Weikkolainen, K., Keski‐Oja, J., & Koli, K. M. (2003) · Growth Factors · doi:10.1080/08977198310001598778 · Cited by 18
Retinoids and TRAIL: Two Cooperating Actors to Fight Against Cancer
Altucci, L., & Gronemeyer, H. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)67017-8 · Cited by 23
Self-citationCao, D., Meng, Y., Li, S., Xin, J., Ben, S., Cheng, Y., Wang, M., Hua, L., & Cheng, G. (2020) · Cancer Medicine · doi:10.1002/cam4.3538 · Cited by 21
Highly Potent Naphthofuran‐Based Retinoic Acid Receptor Agonists
Pérez‐Santín, E., Khanwalkar, H., Voegel, J. J., Collette, P., Mauvais, P., Gronemeyer, H., & de Lera, Á. R. (2009) · ChemMedChem · doi:10.1002/cmdc.200900015 · Cited by 18
Self-citationRetinoic Acid as a Modulator of the Activity of Protein Kinase Cα
López-Andreo, M. J., Torrecillas, A., Conesa‐Zamora, P., Corbalán‐García, S., & Gómez-Fernández, J. C. (2005) · Biochemistry · doi:10.1021/bi0504862 · Cited by 18
Rodríguez, A., Díez, C., Caamaño, J. N., de Frutos, C., Royo, L. J., Muñoz, M., Ikeda, S., Facal, N., Álvarez‐Viejo, M., & Gómez, E. (2007) · Theriogenology · doi:10.1016/j.theriogenology.2007.08.007 · Cited by 19
“Thus, apoptosis in the bovine embryo could be mediated both by RXR and RAR, as in many other tissues under different circumstances [46].”
The p73 Gene Is an Anti-Tumoral Target of the RARβ/γ-Selective Retinoid Tazarotene
Papoutsaki, M., Lanza, M., Marinari, B., Nisticò, S. P., Moretti, F., Levrero, M., Chimenti, S., & Costanzo, A. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23498.x · Cited by 18
“Tazarotene is a retinoid whose properties are the result of a rationale approach to drug design”
BackgroundPapacleovoulou, G., Edmondson, R. J., Critchley, H., Hillier, S. G., & Mason, J. I. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.010 · Cited by 21
Karamouzis, M. V., Sotiropoulou‐Bonikou, G., Vandoros, G. P., Varakis, I., & Papavassiliou, A. G. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.002 · Cited by 18
Reeda, V. S. J., Divya, P., Karthick, T., Jothy, V. B., Alharbi, N. S. H. A., Kadaikunnan, S., Manikandan, A., & Muthu, S. (2024) · Spectroscopy Letters · doi:10.1080/00387010.2024.2359114 · Cited by 17
Bioactive prenylated xanthones from the stems ofCratoxylum cochinchinense
Duan, Y., Dai, Y., Wang, G., Chen, L., Chen, H., Zeng, D., Li, Y.-L., & Yao, X. (2015) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2015.1043902 · Cited by 17
Souza, C. H. D. M., Valli, V. E., Selting, K. A., Kiupel, M., & Kitchell, B. E. (2010) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2010.0571.x · Cited by 17
Chemoprevention of hepatocellular carcinoma by acyclic retinoid
Shimizu, M., Sakai, H., & Moriwaki, H. (2010) · Frontiers in bioscience · doi:10.2741/3718 · Cited by 19
Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells
Vertuani, S., Dubrovska, E., Levitsky, V., Jager, M. J., Kiessling, R. W., & Levitskaya, J. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0185-z · Cited by 18
Liu, L., Liu, L., Leung, L.-H., Cooney, A. J., Chen, C., Rosengart, T. K., Ma, Y., & Yang, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.634790 · Cited by 19
“At physiological concentrations (10 9 10 8 M), ATRA binds to the RAR -RXR heterodimer and induces dissociation of corepressors interchangeably with association of the coactivator complex, including CBP/p300, causing chromatin decondensation and activation of transcription (29).”
BackgroundNovel non-carboxylic acid retinoids: 1,2,4-Oxadiazol-5-one derivatives
Charton, J., Deprez-Poulain, R. F., Hennuyer, N., Tailleux, A., Staels, B., & Deprez, B. P. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.040 · Cited by 17
Control of gene expression by modulated self-assembly
Vilar, J. M. G., & Saiz, L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr272 · Cited by 21
“Nuclear retinoid receptors are highly significant because they mediate the pleiotropic effects of retinoic acid, which include cell proliferation, differentiation and embryonic development and affect the carcinogenic process in a number of organs (32).”
BackgroundAppierto, V., Tiberio, P., Cavadini, E., Casalini, P., Cappelletti, G., & Formelli, F. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0798 · Cited by 17
“However, the interactions with nuclear receptors do not explain all the growth-inhibitory and apoptotic effects displayed by retinoids (3).”
BackgroundTao, Q., Cheng, Y., Clifford, J. L., & Lotan, R. (2003) · Genomics · doi:10.1016/s0888-7543(03)00237-4 · Cited by 17
Offterdinger, M., Schneider, S. M., & Grunt, T. W. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10237 · Cited by 17
“…receptor expression (Flicker et al., 1997; Schneider et al., 2000) and decrease c-erbB-2, -3, and -4 receptor levels in breast cancer cells (Bacus et al., 1990; Peles et al., 1993; Grunt et al., 1998; Offterdinger et al., 1998, 1999; Schneider et al., 1999) suggesting that cross-talk…”
BackgroundLaso, N., Mas, S., Lafuente, M. J., Casterad, X., Trías, M., Ballesta, A. M., Molina, R., Salas‐Salvadó, J., Ascaso, C., Zheng, S., et al. (2004) · PubMed · Cited by 19
Maalmi, H., Walter, V., Jansen, L., Owen, R. W., Ulrich, A., Schöttker, B., Chang-Claude, J., Hoffmeister, M., & Brenner, H. (2018) · Nutrients · doi:10.3390/nu10040510 · Cited by 16
Immune Regulator Vitamin A and T Cell Death
Engedal, N. (2011) · Vitamins and hormones · doi:10.1016/b978-0-12-386960-9.00007-1 · Cited by 16
Genome-wide studies of nuclear receptors in cell fate decisions
Mendoza-Parra, M. A., & Gronemeyer, H. (2013) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.07.001 · Cited by 18
“[7] Altucci L, Gronemeyer H.”
Self-citationHe, M., Zhang, Q., Shu, G., Lin, J.-C., Zhao, L., Liang, X.-X., Yin, L., Shi, F., Fu, H., & Yuan, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.030 · Cited by 16
Human Tribbles homolog 1 functions as a negative regulator of retinoic acid receptor
Imajo, M., & Nishida, E. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01445.x · Cited by 19
“Retinoids have tumorsuppressive activity, and consequently, loss of normal RAR function in the presence of physiologic levels of RA is associated with the progression of a diverse range of cancers (Altucci & Gronemeyer 2001; Freemantle et al. 2003).”
BackgroundNadendla, E. K., Teyssier, C., Delfosse, V., Vivat, V., Gunasekaran, K., Gronemeyer, H., Bourguet, W., & Germain, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123195 · Cited by 16
Self-citationAll‐trans retinoic acid eluting poly(diol citrate) wafers for treatment of glioblastoma
Jones, T. D., Zhang, B., Major, S., & Webb, A. R. (2019) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34416 · Cited by 17
Chemoprevention of liver carcinogenesis with retinoids: Basic and clinical aspects
Moriwaki, H., Shimizu, M., Okuno, M., & Nishiwaki‐Matsushima, R. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00201.x · Cited by 16
Nakazato, T., Okudaira, T., Ishikawa, C., Nakama, S., Sawada, S., Tomita, M., Uchihara, J., Taira, N., Masuda, M., Tanaka, Y., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00917.x · Cited by 16
RetractedIn vivo and Microarray Analysis of Rexinoid-Responsive Anaplastic Thyroid Carcinoma
Klopper, J. P., Berenz, A., Hays, W. R., Sharma, V., Pugazhenthi, U., Janssen, J., Singh, M., Bissonnette, R. P., & Haugen, B. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0269 · Cited by 17
“, 9-cis retinoic acid), specifically activate RXR receptors leading to an alteration in transcription (7).”
BackgroundMulvihill, M. J., Kan, J. L. C., Beck, P., Bittner, M., Cesario, C., Cooke, A. R., Keane, D. M., Nigro, A., Nillson, C., Smith, V., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.044 · Cited by 18
Rethmeier, A., Aggerholm, A., Olesen, L. H., Juhl‐Christensen, C., Nyvold, C. G., Guldberg, P., & Hokland, P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06014.x · Cited by 16
Pyrazine Arotinoids with Inverse Agonist Activities on the Retinoid and Rexinoid Receptors
García, J., Khanwalkar, H., Pereira, R., Erb, C., Voegel, J. J., Collette, P., Mauvais, P., Bourguet, W., Gronemeyer, H., & de Lera, Á. R. (2009) · ChemBioChem · doi:10.1002/cbic.200900030 · Cited by 15
Self-citationZhou, Q., Zhang, L., Chen, Z., Zhao, P.-G., Ma, Y., Yang, B., He, Q., & Ying, M. (2014) · FEBS Journal · doi:10.1111/febs.12840 · Cited by 15
Sakai, H., Shirakami, Y., & Shimizu, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i1.394 · Cited by 15
Luu, T. H., Frankel, P. H., Beumer, J. H., Lim, D. W., Cristea, M. C., Appleman, L. J., Lenz, H., Gandara, D. R., Kiesel, B. F., Piekarz, R., et al. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03955-7 · Cited by 15
Insights on PRAME and osteosarcoma by means of gene expression profiling
de Toledo, S. R. C., Oliveira, I. D., Tesser‐Gamba, F., Torre, C. A. D., Alves, M. T. D. S., Jesús-García, R., Petrilli, A. S., Zago, M. A., Proto‐Siqueira, R., Silva, W. A., et al. (2011) · Journal of Orthopaedic Science · doi:10.1007/s00776-011-0106-7 · Cited by 15
“Recent data indicate that PRAME may be instrumental in disease progression as it interferes with retinoic acid (RA) receptor (RAR) signaling [7–9].”
BackgroundAlcohol intake aggravates adipose browning and muscle atrophy in cancer-associated cachexia
Wang, B., Zhang, F., Zhang, H., Wang, Z., Ma, Y., Zhu, M. J., & Du, . (2017) · Oncotarget · doi:10.18632/oncotarget.22243 · Cited by 16
Control of gene expression by modulated self-assembly
Vilar, J. M. G., & Saiz, L. (2011) · Cited by 15
HIGH-RISK NEUROBLASTOMA: A Therapy in Evolution
Fong, A. P., & Park, J. R. (2009) · Pediatric Hematology and Oncology · doi:10.3109/08880010903121173 · Cited by 16
“The latter is reversed in the presence of RAR ligands, such as cis-RA [38].”
BackgroundSuzui, M., Sunagawa, N., Chiba, I., Moriwaki, H., & Yoshimi, N. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.5.1193 · Cited by 15
Okudaira, T., Tomita, M., Uchihara, J., Matsuda, T., Ishikawa, C., Kawakami, H., Masuda, M., Tanaka, Y., Ohshiro, K., Takasu, N., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0434 · Cited by 17
“to bind a variety of synthetic retinoids (45).”
BackgroundVitamin A: a key coordinator of host-microbe interactions in the intestine
Bang, Y. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0005 · Cited by 14
“The coactivators interact with histone acetylases (HATs) which lead to chromatin decompaction and allow access to DNA by transcriptional machinery (27, 28).”
Novel Fluorescence Competition Assay for Retinoic Acid Binding Proteins
Tomlinson, C. W. E., Chisholm, D. R., Valentine, R., Whiting, A., & Pohl, E. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00420 · Cited by 16
Kato, Y., Egusa, C., Maeda, T., & Tsuboi, R. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.10.016 · Cited by 14
“Published by Elsev tumor growth, and invasion in a variety of tissues as well as having a therapeutic effect due to their antiproliferative, differentiative, and apoptosis-inducing properties [1–3].”
BackgroundPro-proliferative function of the long isoform of PML-RARα involved in acute promyelocytic leukemia
Tussié-Luna, M. I., Rozo, L., & Roy, A. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209388 · Cited by 15
“…to retinoic acid response elements (RARE) and act as a dominant silencing transcription factor that represses transcription activation mediated by the RAR-RXR heterodimer, which is still produced from the intact RARa allele (Lin and Evans, 2000; Minucci et al., 2000; Altucci and Gronemeyer, 2001).”
BackgroundInfluentialEnomoto, Y., Enomoto, K., Kitamura, T., & Kanda, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207653 · Cited by 14
RXR signaling targeted cancer therapy
Zhao, W., Li, S., Chen, R., Ni, J., Huang, X., Li, S., Lü, X., & Cao, X. (2023) · The Innovation Life · doi:10.59717/j.xinn-life.2023.100014 · Cited by 13
Hierarchical self-recognition and response in CSC and non-CSC micro-niches for cancer therapy
Yang, Y., Peng, Y., Du, Y., Lin, M. S., Li, J., Gao, D., Yang, Z., Wang, W., Zhou, Y., Li, X., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122581 · Cited by 14
PML: Not all about Tumor Suppression
Martín-Martín, N., Sutherland, J. D., & Carracedo, A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00200 · Cited by 17
“The PML-RARα fusion protein not only alters PML function but also represses transcriptional activity mediated by RARRXR, thereby disrupting retinoid signaling, inhibiting myeloid differentiation and enhancing the survival and proliferation of early myeloid progenitors (5).”
BackgroundMosquera, N., Rodríguez-Trillo, Á., Mera, A., Gonzalez, A., & Conde, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-26027-x · Cited by 16
Álvarez, S., Pazos-Randulfe, Y., Khanwalkar, H., Germain, P., Álvarez, R., Gronemeyer, H., & de Lera, Á. R. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.09.069 · Cited by 13
Self-citationHuang, C., Lyu, S.-C., Chen, J., & Hu, M. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003473 · Cited by 13
“Further studies are needed to prove that BI may exert anti-metastatic effects through the RXR pathway.”
BackgroundInfluentialXu, K., Guidez, F., Glasow, A., Chung, D., Petrie, K. R., Stegmaier, K., Wang, K.-K., Zhang, J., Jing, Y., Zelent, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1056 · Cited by 14
“The ability of retinoids to arrest growth, induce differentiation, and cause apoptosis of a variety of malignant cell types has distinguished them as potentially important anticancer agents (30).”
BackgroundTargeting sarcoma tumor-initiating cells through differentiation therapy
Han, D., Rodríguez-Bravo, V., Charytonowicz, E., Demicco, E. G., Domenech, J. M. D., Maki, R. G., & Cordon‐Cardo, C. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.04.004 · Cited by 13
“All-trans retinoic acid (ATRA) is one of the best studied and successful molecules used in differentiation-induced treatment, achieving long-term remissions and even cures in treating certain human cancers, including acute promyelocytic leukemia (Altucci and Gronemeyer, 2001).”
BackgroundInfluence of RARalpha gene on MDR1 expression and P-glycoprotein function in human leukemic cells.
Stromskaya, T. P., Rybalkina, E. Y., Заботина, Т. Н., Shishkin, A. A., & Stavrovskaya, A. A. (2005) · Cancer Cell International · doi:10.1186/1475-2867-5-15 · Cited by 13
“In the last decade retinoids became implicated into the treatment of leukemia and some solid tumors [6].”
Sun, W., Carroll, P. J., Soprano, D. R., & Canney, D. J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.081 · Cited by 13
Koçdor, H., Koçdor, M. A., Canda, T., Gürel, D., Çehreli, R., Yılmaz, O., Alakavuklar, M. N., & Güner, G. (2009) · Clinical & Translational Oncology · doi:10.1007/s12094-009-0347-5 · Cited by 13
“Several nuclear hormone receptor ligands including RAR/ RXR and PPAR-γ have been found to be effective for the prevention and treatment of several neoplasms in experimental models [7, 8, 10, 12].”
BackgroundBalasubramanian, S., Chandraratna, R. A. S., & Eckert, R. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208586 · Cited by 13
“Retinoids are important potential cancer therapy and prevention agents (Altucci and Gronemeyer, 2001; Fontana and Rishi, 2002; Hammond et al., 2002; Ortiz et al., 2002; Sun and Lotan, 2002).”
BackgroundShan, P., Xu, W., Huang, Z., Pu, J., & Huang, W. (2014) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.issn.1920-8642.2014.02.008 · Cited by 13
Molecular Targets for Cancer Therapy and Prevention
Gazdar, A. F., Miyajima, K., Reddy, J., Sathyanarayana, U. G., Shigematsu, H., Suzuki, M., Takahashi, T., & Shivapurkar, N. (2004) · CHEST Journal · doi:10.1378/chest.125.5_suppl.97s-a · Cited by 13
Identification of a Novel Non-retinoid Pan Inverse Agonist of the Retinoic Acid Receptors
Busby, S. A., Kumar, N., Kuruvilla, D. S., Istrate, M. A., Conkright, J. J., Wang, Y., Kamenecka, T. M., Cameron, M. D., Roush, W. R., Burris, T. P., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb100396s · Cited by 12
Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells
Reinhardt, A., Liu, H., Ma, Y., Zhou, Y., Zang, C., Habbel, J.-P., Possinger, K., & Eucker, J. (2018) · Anticancer Research · doi:10.21873/anticanres.12509 · Cited by 13
Özpolat, B., Akar, U., Zorrilla, I. R., Vivas‐Mejía, P. E., Acevedo‐Alvarez, M., & Lopez‐Berestein, G. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0222-9 · Cited by 13
“All-trans-retinoic acid (ATRA) a naturally occurring metabolite of retinol (vitamin A) induces cellular differentiation of APL cells in vitro and in vivo [6–11].”
Li, H., He, P., Lin, T.-F., Guo, H., Li, Y., Song, Y., Wang, B., Liu, C., Liu, L., Li, J., et al. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13866 · Cited by 11
Rodon, J. A., Jacobs, C., Chu, Q. S.-C., Rowinsky, E. K., Lopez‐Anaya, A., Takimoto, C. H. M., & Wakelee, H. A. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1770-1 · Cited by 11
Natural and synthetic retinoids in preclinical colorectal cancer models
Abdel‐Samad, R., Aouad, P., & Darwiche, N. (2019) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000802 · Cited by 13
Metadata
- Authors
- Altucci, L., & Gronemeyer, H.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature Reviews Cancer
- Published
- 2001-12
- Volume
- 1
- Issue
- 3
- Pages
- 181-193
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1964224609
- Cited by
- 773
- References
- 147
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 16 · 2023: 18 · 2022: 12 · 2021: 16 · 2020: 20 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 25 · 2015: 36 · 2014: 25 · 2013: 32 · 2012: 47
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- retinoids, cancer therapy, cancer prevention, tumor suppression, antiproliferative mechanism, teratogenicity, cell proliferation
- MeSH terms
- Antineoplastic Agents, Cell Differentiation, Forecasting, Humans, Models, Biological, Morphogenesis, Neoplasm Proteins, Neoplasms, Retinoids, Skin Neoplasms, Structure-Activity Relationship, Vitamin A, Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, Transcriptional Activation, Gene Expression Regulation, Neoplastic, Anticarcinogenic Agents, Apoptosis, Receptors, Retinoic Acid, Transcription Factor AP-1, Dimerization, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.